Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
teer decrease » greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
149621
Perspectives on research DTTC (Thomas et al., 2025)
Published 2025“…<i>American Journal of Speech-Language Patholog</i><i>y, </i><i>34</i>(4S), 2509–2518. <a href="https://doi.org/10.1044/2024_AJSLP-24-00228" rel="noreferrer" target="_blank">https://doi.org/10.1044/2024_AJSLP-24-00228</a></p><p dir="ltr"><b>Publisher Note:</b> This article is part of the Special Issue: Select Papers From the 2024 Conference on Motor Speech—Clinical Science and Implications.…”
-
149622
Spike inference applied to Pavlovian conditioning <i>in vivo</i> imaging data recapitulates transient cue responses, pauses following reward omission, and previously reported relat...
Published 2021“…Neurons that exhibited a significant decrease in firing following reward omission (22/65 neurons; 33.9% of population) are darker green. …”
-
149623
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An <i>in vitro</i> and <i>in vivo</i> approach
Published 2018“…To validate data previously obtained by array analysis, the CLBL-1 cell line was used and the <i>HOXD10</i>, <i>FGFR2</i>, <i>ITIH5</i> and <i>RASAL3</i> genes were selected. …”
-
149624
-
149625
-
149626
-
149627
-
149628
-
149629
-
149630
-
149631
Image8_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149632
Table1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.XLSX
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149633
Image4_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149634
Image3_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149635
Image5_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149636
Video1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.mov
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149637
Image1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149638
DataSheet1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.docx
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149639
Image2_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
-
149640
Image7_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF
Published 2022“…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”